Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Bionomics successfully completes safety studies in animals of antianxiety drug BNC-210

Dec. 22, 2008

KeyNeurotek completes patient recruitment in phase IIa study of KN38-7271 in TBI

Dec. 22, 2008

New agents for psychiatric disorders described in recent Lilly and NeuroSearch patents

Dec. 19, 2008

Recent patents divulge novel analgesic agents

Dec. 19, 2008

Lundbeck initiates phase III trials with desmoteplase in ischemic stroke

Dec. 19, 2008

FDA accepts Transcept's Intermezzo NDA for review

Dec. 19, 2008

Adlea significantly reduces pain after total knee replacement in phase III trial

Dec. 19, 2008

Novel analgesic agents imparted in recent patent literature

Dec. 18, 2008

BioDelivery Sciences resubmits NDA for Onsolis to FDA

Dec. 18, 2008

Phase IIa clinical trial results of LX-6171 in AAMI lead to reevaluation of future development

Dec. 18, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...